Pages that link to "Q52019775"
Jump to navigation
Jump to search
The following pages link to Activating mutations in the gene encoding Kir6.2 alter fetal and postnatal growth and also cause neonatal diabetes. (Q52019775):
Displaying 19 items.
- Pathogenesis of the metabolic syndrome: insights from monogenic disorders (Q27024024) (← links)
- Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene (Q28469173) (← links)
- Type 2 diabetes risk alleles near ADCY5, CDKAL1 and HHEX-IDE are associated with reduced birthweight. (Q33583643) (← links)
- Type 2 diabetes TCF7L2 risk genotypes alter birth weight: a study of 24,053 individuals (Q35788544) (← links)
- Permanent neonatal diabetes mellitus (Q36739273) (← links)
- Expression of an activating mutation in the gene encoding the KATP channel subunit Kir6.2 in mouse pancreatic beta cells recapitulates neonatal diabetes (Q37036031) (← links)
- Type 2 diabetes risk alleles are associated with reduced size at birth (Q37193702) (← links)
- Examination of type 2 diabetes loci implicates CDKAL1 as a birth weight gene. (Q37360480) (← links)
- Diabetes mellitus in neonates and infants: genetic heterogeneity, clinical approach to diagnosis, and therapeutic options (Q37446924) (← links)
- Genetic susceptibility to type 2 diabetes and obesity: follow-up of findings from genome-wide association studies. (Q37639793) (← links)
- Genome-wide association studies (GWAS): impact on elucidating the aetiology of diabetes. (Q37883249) (← links)
- Management of sulfonylurea-treated monogenic diabetes in pregnancy: implications of placental glibenclamide transfer. (Q38756971) (← links)
- Not All Diabetes in Infants is Type 1: A Case Report (Q41767426) (← links)
- Early origins of child obesity: bridging disciplines and phases of development -- September 30--October 1, 2010. (Q43188686) (← links)
- Genetic influences on the association between fetal growth and susceptibility to type 2 diabetes (Q44958481) (← links)
- Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide. (Q45939977) (← links)
- Clinical Management of Women with Monogenic Diabetes During Pregnancy (Q49948560) (← links)
- Fetal macrosomia and neonatal hyperinsulinemic hypoglycemia associated with transplacental transfer of sulfonylurea in a mother with KCNJ11-related neonatal diabetes. (Q55426344) (← links)
- Neonatal diabetes: genetic implications in treatment (Q84961607) (← links)